Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Hindustan Unilever Board approves merger of HUL and GlaxoSmithKline Consumer Healthcare Limited

Posted On: 2018-12-03 14:08:43

The Board of Directors of Hindustan Unilever Limited (HUL) today approved a scheme of amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH India) subject to obtaining requisite approvals from statutory authorities and shareholders. HUL has reached a definite agreement with GSK CH India in this regard. The transaction is an all equity merger with 4.39 shares of HUL being allotted for every share in GSK CH India. This transaction values the total business at INR 317 bln.

A unique opportunity to acquire the No. 1 Health Food Drinks (HFD) portfolio in the largest HFD market globally

The acquisition is in line with the Hindustan Unilever strategy to build a sustainable and profitable Foods and Refreshment (F&R) business in India by leveraging the mega trend of health and wellness. GSK CH India is the market leader in the HFD category, with iconic brands such as Horlicks and Boost, and a product portfolio supported by strong nutritional claims. This portfolio has a long history in India with Horlicks having originally been introduced in the 1930s. Horlicks products have been an everyday staple in households across generations.

HUL can unlock significant synergies both from revenue and costs

The average growth rate has been double digit over the last decade, and the category still remains under-penetrated in India. HUL is well positioned to further develop the market given the extent of its reach and capabilities. We will increase penetration with special focus on rural markets and emerging channels and expand our offerings to the fast-growing premium segment. Customer development, we believe, will be a growth multiplier given our direct coverage and technology led capabilities. We will drive significant cost synergies from a combination of supply chain efficiencies and operational improvements, go-to-market and distribution network optimisation, scale in a number of cost areas such as marketing and streamlining of overlapping infrastructure. We expect the business to grow in double-digits in the medium-term and margins to be accretive to HUL post realisation of synergy benefits.

HUL an FCMG powerhouse with proven track record

HUL is the number 1 FMCG business in the country with a demonstrated track record of delivering growth which is competitive, profitable, sustainable and responsible. Business has delivered growth of 10% CAGR in the last 10 years with EBIT improvement of 530bps.

Sanjiv Mehta, Chairman and Managing Director, HUL said, "With this proposed strategic merger with GSK CH India, we will be expanding our portfolio with great brands into a new category catering to the nutritional needs of our consumers. I am confident that this merger will create significant shareholder value through both revenue growth and cost synergies. The turnover of our F&R business will exceed Rs.100 bn and we will become one of the largest F&R businesses in the country. We look forward to welcoming new brands and great talent into the Unilever and HUL family, once the transaction is complete."

About the deal

The GSK CH India business delivered total turnover of around INR 42 billion in the year ended March 2018, primarily through its Horlicks and Boost brands.

The merger of GSK CH India with HUL will be on a basis of an exchange ratio of 4.39 HUL shares for each GSK CH India Share, implying a total equity value of INR 317 bln for 100% of GSK CH India. Following the issue of new HUL shares, Unilever's holding in HUL will be diluted from 67.2% to 61.9%.

The merger includes the totality of operations within GSK CH India, including a consignment selling contract to distribute GSK CH India's Over-the-Counter and Oral Health products in India.

The transaction is expected to be completed in one year subject to regulatory and shareholder approvals.

Shares of HINDUSTAN UNILEVER LTD. was last trading in BSE at Rs.1771.8 as compared to the previous close of Rs. 1765.35. The total number of shares traded during the day was 86702 in over 2682 trades.

The stock hit an intraday high of Rs. 1796.7 and intraday low of 1742.25. The net turnover during the day was Rs. 152768678.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

IFCI Ltd reports loss of Rs. 16.55 crores in Q2 FY19

Muthoot Finance Ltd Q2 FY19 PAT climbs to Rs. 483.83 crores

IndiGo brings its school adoption programme to Vadodara; adopts 15 government schools

WhizAI raises $1.1 Million in Seed Funding Led by Trigyn Technologies, Inc.

ETT Ltd appoints director

Power Grid declared as successful bidder under TBCB

Sagar Cements Ltd approves new projects

Avenue Supermarts Ltd issues Commercial Paper of Rs. 100 crore

UROS Group joins forces with Tata Communications to accelerate IoT and Smart City projects

ICICI Bank Ltd announces change of Government Nominee Director

Nestle India Limited Board approves Dividend of Rs. 50

Ravalgaon Sugar Farm Ltd approves sale of land, machinery

Spice Mobility Ltd announces resignation of CFO

Indian Hume Pipe Company Ltd receives LoA for work of Rs. 204.51 crores

Lemon Tree Hotels Ltd opens new hotel at Connaught Road, Pune

Mr Milan Paleja to step down from Novartis India Ltd

Brickwork Ratings upgrades rating of Xpro India Ltd

Indo Gulf Industries Ltd announces change in CS

Tasty Dairy Specialties Ltd inks MoU with Foundation Dutch Greenhouse Delta

PVP Ventures Ltd appoints additional director

AARV Infratel Ltd enters into term sheet with Quess Corp

Maruti Suzuki India mulls price increase from January 2019

Capital India Finance Ltd board to consider rights issue

US FDA completes inspection of Lupin's Mandideep location

SEAMEC III commences 1 year charter with ONGC

Sri Amarnath Finance Ltd announces resignation of CS

Promoter announces offer for sale of shares of RattanIndia Infrastructure Ltd

L&T Construction wins orders valued Rs.2106 Crore

Alembic Pharmaceuticals receives USFDA Approval for Candesartan Cilexetil Tablets USP, 4 mg, 8 mg, and 16 mg.

Divya Jyoti Industries Limited announces resignation of CS

NTPC Wins 85 MW Solar Capacities in UPNEDA's 550 MW Solar Tender

SISL Board approves the scheme of amalgamation of Total Securities with the Company

Rural Electrification Corporation Ltd reports Q2 FY19 PAT of Rs. 1764.33 crores

IL&FS Investment Managers Ltd board to consider Q2 results on Dec 14, 2018

Opto Circuits India Ltd board to announce Q3 results on Feb 12, 2019

Oriental Aromatics Ltd fixes Dec 14, 2018 as record date for bonus issue, stock split

Bosch Ltd appoints Dr. Gopichand Katragadda as an Additional Director

ITC Savlon introduces Braille enabled Packs of antiseptic liquid

MY FM launches 5th edition of 'MY FM Rangrezz'

Gaurs Group gives exit to Indiabulls, pays Rs 340 crores debt

Allen Solly recreates innovative 'Open Work Culture' for Moviegoers

Jain Farm Fresh launches Valley Spice range

Capri Global Capital Limited appoints Mr. Ajay Kumar Relan as independent director

Veto Switchgears and Cables Ltd calls for board meeting on Dec 15, 2018

Alna Trading & Exports Ltd appoints CS

Mr. Rikenkumar Dalwadi appointed as compliance officer of EIMCO Elecon India Ltd

Kesoram Industries Ltd approves demerger of tyre business to Birla Tyres Ltd

The New India Assurance Company Ltd announces change in Chairman and MD

Trigyn Technologies Inc. declares dividend to Trigyn Technologies Limited

Kridhan Infra Ltd's associate company Vijay Nirman Company wins order worth INR 105 crores







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018